13F HOLDINGS REPORT
Paradigm Biocapital Advisors LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001855655-23-000006
Total Value
$1.06B
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOGEN INC | BIIB | 349,593 | $97.2M | 9.21% |
| 2 | INCYTE CORP | INCY | 1,261,711 | $91.2M | 8.64% |
| 3 | LEGEND BIOTECH CORP | LEGN | 1,510,324 | $72.8M | 6.90% |
| 4 | ARGENX SE | ARGX | 181,172 | $67.5M | 6.40% |
| 5 | SEAGEN INC | SE | 281,969 | $57.1M | 5.41% |
| 6 | IMMUNOCORE HLDGS PLC | IMCR | 1,126,256 | $55.7M | 5.28% |
| 7 | ARCELLX INC | ACLX | 1,757,779 | $54.2M | 5.13% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,085,698 | $53.1M | 5.03% |
| 9 | MIRATI THERAPEUTICS INC | 60468T105 | 1,396,779 | $51.9M | 4.92% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,274,512 | $48.0M | 4.55% |
| 11 | UNITED THERAPEUTICS CORP DEL | UTHR | 211,892 | $47.5M | 4.50% |
| 12 | KEROS THERAPEUTICS INC | KROS | 930,752 | $39.7M | 3.77% |
| 13 | BEIGENE LTD | BEIGF | 184,012 | $39.7M | 3.76% |
| 14 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 1,595,199 | $38.9M | 3.69% |
| 15 | BICYCLE THERAPEUTICS PLC | BCYC | 1,816,781 | $38.6M | 3.66% |
| 16 | ASCENDIS PHARMA A/S | ASND | 350,866 | $37.6M | 3.57% |
| 17 | VOR BIOPHARMA INC | VOR | 6,477,999 | $34.9M | 3.30% |
| 18 | ZAI LAB LTD | ZLAB | 780,558 | $26.0M | 2.46% |
| 19 | XENON PHARMACEUTICALS INC | XENE | 651,068 | $23.3M | 2.21% |
| 20 | VERONA PHARMA PLC | 925050106 | 962,361 | $19.3M | 1.83% |
| 21 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,133,782 | $18.2M | 1.73% |
| 22 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,317,634 | $17.9M | 1.70% |
| 23 | THESEUS PHARMACEUTICALS INC | 88369M101 | 1,505,327 | $13.4M | 1.27% |
| 24 | OLEMA PHARMACEUTICALS INC | OLMA | 2,382,377 | $8.3M | 0.78% |
| 25 | POSEIDA THERAPEUTICS INC | 73730P108 | 1,072,410 | $3.3M | 0.31% |